Figure 5From: The effect of Lactobacillus brevis KB290 against irritable bowel syndrome: a placebo-controlled double-blind crossover trialIntestinal microflora. Changes in the percentages of the genera Bifidobacterium and Clostridium were compared by T-RFLP analysis. As a result, the percentage of the genus Bifidobacterium was significantly higher, and that of the genus Clostridium was significantly lower, after test capsule consumption than after placeb consumption.Back to article page